<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03752476</url>
  </required_header>
  <id_info>
    <org_study_id>Dossot</org_study_id>
    <nct_id>NCT03752476</nct_id>
  </id_info>
  <brief_title>Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria</brief_title>
  <acronym>INOR Blact</acronym>
  <official_title>Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug
      resistant bacteria colonization in intensive care

      It's retrospective case controle study. Cases are colonized patient by multidrug resistant
      bacteria hospitalized in intensive care during the fist hospitalization in intensive care.
      Temoin are patients with the same characteristics than case but no colonized by multidrug
      resistant bacteria.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The emergence of multidrug resistant is a wordwide problem. B lactam resistant increase. The
      antibiotic prescription impact this problem.

      B lactam antibiotic is prescribed everyday in intensive care unit. The switch of antibiotic
      is common. Antibiotic classes inclue a lot of rank with different spectum that impact the
      occurrence of resistant.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of Beta lactam class prescription</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Resistant Infection</condition>
  <condition>Antibiotic Resistant Infection</condition>
  <condition>Beta Lactam Resistant Bacterial Infection</condition>
  <condition>Bacterial Resistance</condition>
  <arm_group>
    <arm_group_label>case</arm_group_label>
    <description>Patients are colonized patient by antimicrobial bacteria hospitalized in intensive care during the fist hospitalization in intensive care during 2016-2017.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>Patients aren't colonized patient by antimicrobial bacteria hospitalized in intensive care during the fist hospitalization in intensive care during 2016-2017.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>number of Beta lactam class prescription for the same infection</intervention_name>
    <description>Each number of Beta lactam prescription without interruption are compared</description>
    <arm_group_label>case</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patient hospitalized more than 48 hours in intensive care unit in Besançon between
        january 2016 and december 2017
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patient hospitalized more than 48 hours in intensive care unit in Besançon between
             january 2016 and december 2017

        Exclusion Criteria:

          -  patient under guardianship

          -  patient allergic to Beta lactam

          -  colonization with mutidrug resistant the first week of hospitalization in intensive
             care unit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>ESTELLE DOSSOT</last_name>
    <phone>+33645578372</phone>
    <email>estelle.dossot@gmail.com</email>
  </overall_contact>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 21, 2018</study_first_submitted>
  <study_first_submitted_qc>November 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2018</study_first_posted>
  <last_update_submitted>November 21, 2018</last_update_submitted>
  <last_update_submitted_qc>November 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Besancon</investigator_affiliation>
    <investigator_full_name>Estelle Dossot</investigator_full_name>
    <investigator_title>Internal</investigator_title>
  </responsible_party>
  <keyword>antibiotic resistant</keyword>
  <keyword>multidrug resistant</keyword>
  <keyword>Beta lactam</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactams</mesh_term>
    <mesh_term>beta-Lactams</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

